07:00 , Oct 23, 2000 |  BioCentury  |  Finance

Mutual respect for biotech

Although biotech stocks have taken a drubbing so far this quarter, fund managers do not appear to be getting out of the group or increasing the percentage of cash holdings in their funds. Nor does...
07:00 , Oct 16, 2000 |  BC Extra  |  Financial News

Cellomics raises $30 million

Cell-based drug discovery company Cellomics (Pittsburgh, Penn.) raised $30 million in a private round. Investors included Amerindo Investment Advisors; INVESCO; Alta Partners; Burrill Biotechnology Capital Fund; BayStar Capital; Ariane Health Fund; LCF Rothschild; Biosphere; InterWest...
08:00 , Mar 22, 1999 |  BioCentury  |  Emerging Company Profile

Copernicus Therapeutics Inc.

Copernicus Therapeutics Inc. Beachwood, Ohio Technology: Nonviral delivery and targeting systems for nucleic acids, proteins and small molecule therapeutics Disease focus: Autoimmune/Inflammation, Cancer Clinical status: Preclinical Founded: 1997 by Robert Butz, Mark Cooper, and Charles...